BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19148798)

  • 1. Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials.
    Ishikawa H; Nakamura T; Kawano A; Gondo N; Sakai T
    J Gastroenterol; 2009; 44 Suppl 19():77-81. PubMed ID: 19148798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; Pérez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colorectal neoplasia.
    Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
    ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
    Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
    Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and familial adenomatous polyposis: coming full circle.
    Chan AT
    Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
    Thun MJ; Henley SJ; Patrono C
    J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
    Benamouzig R; Uzzan B; Little J; Chaussade S
    Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colorectal cancer: slow, steady progress.
    Burke CA; Bauer WM; Lashner B
    Cleve Clin J Med; 2003 Apr; 70(4):346-50. PubMed ID: 12701989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin for Chemoprevention of Colorectal Adenoma and Cancer].
    Ishikawa H
    Gan To Kagaku Ryoho; 2021 Dec; 48(12):1425-1428. PubMed ID: 34911904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H; Arber N
    Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
    Asano TK; McLeod RS
    Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is colorectal cancer an avoidable disease nowadays?
    Benamouzig R
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():107-11. PubMed ID: 15588802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs and colorectal cancer prevention.
    Iwama T
    J Gastroenterol; 2009; 44 Suppl 19():72-6. PubMed ID: 19148797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention in hereditary colorectal cancer syndromes.
    Hawk E; Lubet R; Limburg P
    Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.